Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0QVLPN)
| ADC Name |
Mirzotamab-ADC-Tb1-14
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
Mirzotamab ADC Tb1 14
Click to Show/Hide
|
|||||
| Organization |
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2-8
|
|||||
| Structure |
|
|||||
| Antibody Name |
Mirzotamab
|
Antibody Info | ||||
| Antigen Name |
CD276 antigen (CD276)
|
Antigen Info | ||||
| Payload Name |
Mirzotamab-ADC-Tb1-14 payload
|
|||||
| Linker Name |
Mirzotamab-ADC-Tb1-14 linker
|
|||||